Call 888-776-0942 from 8 a.m. to 10 p.m. Eastern Time

The scale of the antibody testing market is driven by the increase in the number of global COVID-19 cases, the increase in the prevalence of chronic diseases, and the growing elderly population. The infectious disease sector accounted for the largest market share in 2019 and is expected to have the highest compound annual growth rate of 8.0% in 2020-2027.

New York, December 14, 2021/PRNewswire/--According to the new market research report "Antibody Testing Market Forecast to 2027-COVID-19 Impact and Global Product Analysis (kits, chemicals and reagents, consumables) ; Indications (pregnancy, cardiovascular diseases, autoimmune diseases, infectious diseases, oncology, endocrine diseases, etc.); end users (hospitals, academic and research institutions, diagnostic laboratories, biopharmaceutical companies) and geography", by Global Antibodies The inspection agency The Insight Partners published a market value of US$6.415.9 billion in 2019 and is expected to reach US$10.74069 billion by 2027; from 2020 to 2027, it is expected to grow at a compound annual growth rate of 6.7%. Get the latest COVID-19 analysis on the antibody testing market at https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00016492

Antibody testing market: competitive landscape and key developments

Thermo Fisher Scientific, Abbott Laboratories, Bio-Rad Laboratories, Inc, Beckton, Dickinson And Company, F. Hoffmann La Roche, Agilent Technologies, Diasorin, Zeus Scientific, Abcam, Trinity Biotech are the major companies operating in the antibody testing market. These players are focusing on expanding and diversifying their market share and acquiring new customer bases in order to tap current business opportunities.

Get an exclusive sample page of the antibody testing market size at https://www.theinsightpartners.com/sample/TIPRE00016492/-COVID-19 impact and strategic insight global analysis

North America has the largest market share and is expected to grow further in the forecast year. The growth of the North American market is characterized by the emergence of new market participants, the release of various products, and increased investment in clinical diagnostics by major market participants.

Similarly, in Mexico, the mature clinical diagnosis business has increased the demand for antibody detection products. As a result, the supply chain and logistics of antibody testing products (such as systems and software for antibody testing, as well as consumables and reagents) have increased. In North America, the United States is the largest market for antibody testing. The United States is the largest and fastest growing market for clinical diagnostics. The market growth is attributed to the increase in research and development, and the application of antibody detection in pregnancy, cardiovascular disease, autoimmune disease, infectious disease, oncology, endocrine disease, diabetes and other indications is increasing. In addition, increasing government support is promoting the growth of antibody testing, which is affecting the growth of the market. For example, the US Food and Drug Administration (FDA) has publicly shared the detection performance data of four antibody or serological test kits. These results come from the collaborative efforts of the FDA, NIH, Centers for Disease Control and Prevention (CDC), and Biomedical Advanced Research and Development Agency (BARDA).

In addition, the country has the largest number of market participants involved in antibody testing research and product development. Market leaders are investing heavily in the development of antibody tests. For example, in January 2013, Bio-Rad acquired AbD Serotec, a division of MorphoSys AG. This has added Serotec's more than 15,000 antibodies, kits and accessories to Bio-Rad's research and clinical diagnostic product portfolio. Similarly, in 2020, Thermo Fisher Scientific (USA) cooperated with Wuxi and Mayo Clinic to obtain FDA authorization to use ELISA to detect COVID-19 to detect IgM and IgG antibodies.

In addition, the increasing incidence of infectious diseases and autoimmune diseases has led to an increasing demand for antibody testing. In addition, the country is undergoing more and more innovative antibody testing startups. Therefore, due to the aforementioned factors, the market is expected to dominate its growth in the future.

Download the sample PDF brochure of the antibody detection market size and growth research report at https://www.theinsightpartners.com/sample/TIPRE00016492/

The Asia-Pacific region is expected to be the fastest growing region of all other regions. The growth of the market in this region is mainly due to the major contributions of countries such as China, India, and Japan. The factors driving the growth of the antibody testing market in these countries include the rapid increase in infectious disease cases over the years and the development of the medical care field.

In addition, due to the increase in the elderly population, the market is expected to grow in the future. The population of developing countries is aging the fastest, which is another major cause of chronic diseases. Such diseases will further increase the market demand for antibody testing.

The number of Covid 19 cases in the growth of the antibody detection market continues to increase:

Since the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was declared a public health emergency of international concern in late January 2020, medical professionals and researchers have been urging the need for comprehensive and rapid treatment of citizens. Testing in order to develop measures that can respond to the epidemic. Stop the spread of the virus. Over time, real-time polymerase chain reaction testing and antibody testing have become important technologies for the global medical system to manage the epidemic. Antibody detection is essential for the differential diagnosis of SARS-CoV-2. It is tested by the patient's serum or plasma and reagent red blood cells. Determining specific antibodies against viral and bacterial pathogens and parasites can help to take the right treatment measures. Antibody testing is essential to implement an effective and efficient public health strategy to minimize the adverse effects of the COVID-19 pandemic. It should be used in important clinical practical cases and support global resumption strategies.

Antibody test kits can predict the prognosis and detection of COVID-19 infection to help the disease. Because these kits help check whether a person has developed antibodies against SARS-CoV-2 in their blood, it indicates whether a person has been exposed to COVID-19 or has COVID-19. To manage the COVID-19 pandemic and increase patient screening, several companies are providing these rapid antibody test kits to healthcare workers, hospitals, laboratories, and other professionals. Therefore, the rise in coronavirus cases and the increase in government approvals for antibody test kits are the few factors driving market growth.

Antibody Testing Market: Overview of Market Segments

According to the product, the antibody detection market is divided into kits, chemicals and reagents, and consumables. In 2019, the market segment based on kits accounted for more than 53.75% of the market share. In terms of indications, the antibody detection market is segmented into pregnancy, infectious diseases, tumors, cardiovascular diseases, endocrine diseases, and autoimmune diseases. The field of infectious diseases accounted for the largest market share in 2019. In terms of end users, the antibody detection market has been subdivided into hospitals, academic and research institutions, diagnostic laboratories, and biopharmaceutical companies. The diagnostic laboratory sector accounted for the largest market share in 2019.

Purchase an advanced copy of the 2020-2027 antibody testing market size, share, revenue, strategic insight and forecast research report at https://www.theinsightpartners.com/buy/TIPRE00016492/

The COVID-19 outbreak has disrupted various industries and businesses around the world. Across the country, various healthcare research centers are only dedicated to researching COVID 19 treatments. In addition, during the initial stage of the COVID-19 crisis, due to lockdowns and supply chain disruptions, the demand for antibody testing was interrupted due to changes in customer behavior. As the crisis progressed, health care professionals realized that the use of innovative technologies to develop new diagnostic methods was essential to alleviate this unprecedented crisis, because in this case, governments around the world did not prepare for this pandemic. Prepare.

To date, no final treatment for COVID 19 has been determined. Therefore, the lack of a clear treatment provides an important opportunity for the antibody testing market, as the US FDA recently approved the use of plasma therapy for critically ill COVID 19 patients. Therefore, in the long run, the antibody testing market will have significant growth prospects. For example, many market participants have obtained emergency use authorization for newly developed antibody tests. In August 2020, the Covid-19 IgG ELISA antibody test of Trinity Biotech, a developer and manufacturer of diagnostic products, has received an emergency use authorization (EUA) from the US FDA. All these developments will increase the future demand for the antibody testing market.

Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients obtain solutions that meet their research needs through our joint and consulting research services. We focus on industries such as semiconductors and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical equipment, technology, media and telecommunications, chemicals and materials.

Contact us: If you have any questions about this report or want more information, please contact us:

Contact: Sameer Joshi Email: [Email protected] Phone: +1-646-491-9876 Press release: https://www.theinsightpartners.com/pr/antibody-testing-market More research: https: // www.openpr.com/news/archive/139407/The-Insight-Partners.html

More news releases on similar topics

Cision Distribution 888-776-0942 8 a.m. to 9 p.m. Eastern Time